(Q51129676)

English

Use of the Stanford Health Assessment Questionnaire in estimation of long-term productivity costs in patients with recent-onset rheumatoid arthritis.

scientific article published in March 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 March 2018

http://europepmc.org/abstract/MED/19274516

Use of the Stanford Health Assessment Questionnaire in estimation of long-term productivity costs in patients with recent-onset rheumatoid arthritis. (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 March 2018

http://europepmc.org/abstract/MED/19274516

1 reference

based on heuristic

inferred from title

rheumatoid arthritis

1 reference

based on heuristic

inferred from title

author name string

K Puolakka

1

1 reference

Europe PubMed Central

PubMed publication ID

30 March 2018

http://europepmc.org/abstract/MED/19274516

H Kautiainen

2

1 reference

Europe PubMed Central

PubMed publication ID

30 March 2018

http://europepmc.org/abstract/MED/19274516

T Mottonen

3

1 reference

Europe PubMed Central

PubMed publication ID

30 March 2018

http://europepmc.org/abstract/MED/19274516

P Hannonen

4

1 reference

Europe PubMed Central

PubMed publication ID

30 March 2018

http://europepmc.org/abstract/MED/19274516

M Korpela

5

1 reference

Europe PubMed Central

PubMed publication ID

30 March 2018

http://europepmc.org/abstract/MED/19274516

M Hakala

6

1 reference

Europe PubMed Central

PubMed publication ID

30 March 2018

http://europepmc.org/abstract/MED/19274516

R Luukkainen

7

1 reference

Europe PubMed Central

PubMed publication ID

30 March 2018

http://europepmc.org/abstract/MED/19274516

K Vuori

8

1 reference

Europe PubMed Central

PubMed publication ID

30 March 2018

http://europepmc.org/abstract/MED/19274516

H Blåfield

9

1 reference

Europe PubMed Central

PubMed publication ID

30 March 2018

http://europepmc.org/abstract/MED/19274516

M Leirisalo-Repo

10

1 reference

Europe PubMed Central

PubMed publication ID

30 March 2018

http://europepmc.org/abstract/MED/19274516

publication date

1 March 2009

1 reference

Europe PubMed Central

PubMed publication ID

30 March 2018

http://europepmc.org/abstract/MED/19274516

Scandinavian Journal of Rheumatology

1 reference

Europe PubMed Central

PubMed publication ID

30 March 2018

http://europepmc.org/abstract/MED/19274516

38

1 reference

Europe PubMed Central

PubMed publication ID

30 March 2018

http://europepmc.org/abstract/MED/19274516

2

1 reference

Europe PubMed Central

PubMed publication ID

30 March 2018

http://europepmc.org/abstract/MED/19274516

96-103

1 reference

Europe PubMed Central

PubMed publication ID

30 March 2018

http://europepmc.org/abstract/MED/19274516

What is the impact of early rheumatoid arthritis on the individual?

1 reference

https://api.crossref.org/works/10.1080%2F03009740902756515

21 January 2018

Health care costs attributable to the treatment of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1080%2F03009740902756515

21 January 2018

The costs of rheumatoid arthritis: an international long-term view

1 reference

https://api.crossref.org/works/10.1080%2F03009740902756515

21 January 2018

Indirect medical costs in early rheumatoid arthritis: composition of and changes in indirect costs within the first three years of disease.

1 reference

https://api.crossref.org/works/10.1080%2F03009740902756515

21 January 2018

Overview of work disability in rheumatoid arthritis patients as observed in cross-sectional and longitudinal surveys

1 reference

https://api.crossref.org/works/10.1080%2F03009740902756515

21 January 2018

Systematic review of studies of productivity loss due to rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1080%2F03009740902756515

21 January 2018

Monetary value of lost productivity over a five year follow up in early rheumatoid arthritis estimated on the basis of official register data on patients' sickness absence and gross income: experience from the FIN-RACo trial.

1 reference

https://api.crossref.org/works/10.1080%2F03009740902756515

21 January 2018

Health economic issues in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1080%2F03009740902756515

21 January 2018

Predictive factors of work disability in rheumatoid arthritis: a systematic literature review

1 reference

https://api.crossref.org/works/10.1080%2F03009740902756515

21 January 2018

Predictors of productivity loss in early rheumatoid arthritis: a 5 year follow up study

1 reference

https://api.crossref.org/works/10.1080%2F03009740902756515

21 January 2018

Early suppression of disease activity is essential for maintenance of work capacity in patients with recent-onset rheumatoid arthritis: five-year experience from the FIN-RACo trial.

1 reference

https://api.crossref.org/works/10.1080%2F03009740902756515

21 January 2018

Modeling the progression of rheumatoid arthritis: a two-country model to estimate costs and consequences of rheumatoid arthritis.

1 reference

https://api.crossref.org/works/10.1080%2F03009740902756515

21 January 2018

Rheumatoid arthritis: what does it cost and what factors are driving those costs? Results of a survey in a community-derived population in Malmö, Sweden

1 reference

https://api.crossref.org/works/10.1080%2F03009740902756515

21 January 2018

The Rheumatoid Arthritis Quality of Life (RAQoL) for Sweden: adaptation and validation.

1 reference

https://api.crossref.org/works/10.1080%2F03009740902756515

21 January 2018

Disability and health-related quality of life among patients with rheumatoid arthritis: association with radiographic joint damage, disease activity, pain, and depressive symptoms.

1 reference

https://api.crossref.org/works/10.1080%2F03009740902756515

21 January 2018

An overview of economic evaluations for drugs used in rheumatoid arthritis : focus on tumour necrosis factor-alpha antagonists

1 reference

https://api.crossref.org/works/10.1080%2F03009740902756515

21 January 2018

How does functional disability in early rheumatoid arthritis (RA) affect patients and their lives? Results of 5 years of follow-up in 732 patients from the Early RA Study (ERAS)

1 reference

https://api.crossref.org/works/10.1080%2F03009740902756515

21 January 2018

Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: a randomised trial. FIN-RACo trial group

1 reference

https://api.crossref.org/works/10.1080%2F03009740902756515

21 January 2018

Retardation of joint damage in patients with early rheumatoid arthritis by initial aggressive treatment with disease-modifying antirheumatic drugs: five-year experience from the FIN-RACo study

1 reference

https://api.crossref.org/works/10.1080%2F03009740902756515

21 January 2018

The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. The Committee on Outcome Measures in Rheumatoid Arthritis Clinical Trials

1 reference

https://api.crossref.org/works/10.1080%2F03009740902756515

21 January 2018

The friction cost method for measuring indirect costs of disease.

1 reference

https://api.crossref.org/works/10.1080%2F03009740902756515

21 January 2018

Early rheumatoid arthritis--some social, economical, and psychological aspects.

1 reference

https://api.crossref.org/works/10.1080%2F03009740902756515

21 January 2018

Modelling the effect of function and disease activity on costs and quality of life in rheumatoid arthritis.

1 reference

https://api.crossref.org/works/10.1080%2F03009740902756515

21 January 2018

Cost effectiveness of etanercept (Enbrel) in combination with methotrexate in the treatment of active rheumatoid arthritis based on the TEMPO trial

1 reference

https://api.crossref.org/works/10.1080%2F03009740902756515

21 January 2018

Productivity costs among patients with rheumatoid arthritis: the influence of methods and sources to value loss of productivity

1 reference

https://api.crossref.org/works/10.1080%2F03009740902756515

21 January 2018

Impact of initial aggressive drug treatment with a combination of disease-modifying antirheumatic drugs on the development of work disability in early rheumatoid arthritis: a five-year randomized followup trial.

1 reference

https://api.crossref.org/works/10.1080%2F03009740902756515

21 January 2018

Work disability in early rheumatoid arthritis: higher rates but better clinical status in Finland compared with the US.

1 reference

https://api.crossref.org/works/10.1080%2F03009740902756515

21 January 2018

Lost Productive Time and Cost Due to Common Pain Conditions in the US Workforce

1 reference

https://api.crossref.org/works/10.1080%2F03009740902756515

21 January 2018

Chronic medical conditions and work performance in the health and work performance questionnaire calibration surveys.

1 reference

https://api.crossref.org/works/10.1080%2F03009740902756515

21 January 2018

Measurement of patient outcome in arthritis

1 reference

https://api.crossref.org/works/10.1080%2F03009740902756515

21 January 2018

The friction cost method: A comment

1 reference

https://api.crossref.org/works/10.1080%2F03009740902756515

21 January 2018

Identifiers

10.1080/03009740902756515

1 reference

Europe PubMed Central

PubMed publication ID

30 March 2018

http://europepmc.org/abstract/MED/19274516

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 March 2018

http://europepmc.org/abstract/MED/19274516

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51129676&oldid=1260521001"